News Daily News Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events Michael O'Riordan April 18, 2019
News Daily News Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD L.A. McKeown April 03, 2019
News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Conference News ACC 2019 Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom Michael O'Riordan March 20, 2019
News Conference News ACC 2019 New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead Michael O'Riordan March 17, 2019
News Daily News Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests Michael O'Riordan February 08, 2019
News Daily News Ethnic Variations in Lp(a) Concentrations Challenge Current Risk Thresholds Yael L. Maxwell January 25, 2019
News Daily News Dose-Response Benefits for Fiber Intake Seen Across Wide Swath of Acquired Diseases Shelley Wood January 15, 2019
News Daily News FOURIER Analysis: Evolocumab Delivers Consistent LDL Cholesterol-Lowering Yael L. Maxwell December 19, 2018
News Daily News Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests Michael O'Riordan December 03, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2018 Shelley Wood November 30, 2018
News Conference News AHA 2018 Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis Caitlin E. Cox November 13, 2018
News Conference News AHA 2018 New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening Michael O'Riordan November 10, 2018
News Daily News ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom Michael O'Riordan November 07, 2018
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Daily News Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering Shelley Wood October 29, 2018